Approval for pain reliever for osteoarthritic knees to be delayed
Genzyme has to provide FDA with more data on Synvisc-One before the pain-relieving treatment for osteoarthritis can be approved.
New warnings added to ESA labels yet again
FDA adds new warnings to erythropoiesis-stimulating agents' labels.
Statin for slowing atherosclerosis progression gets FDA OK
New indication for rosuvastatin (Crestor) approved.
Growth hormone delivery system approved
New delivery device approved for somatropin (Saizen).
Pharmacy students: Our greatest asset or most squandered opportunity?
Pharmacy students should be given good training when they are doing their internships and externships, not used as a replacement for vacationing staff.
New training program addresses high demand for technicians
U.S. Career Institute announces pharmacy technician course.
Action heats up in Congress on PBM bill and AMP rule
Nevada pharmacists demand a vote on Fair Medicaid Drug Payment Act, while House judiciary committee unanimously approves PBM legislation.
Revenues from retail clinics could reach almost $4.5 billion by 2011
A new study finds that Retail clinic's revenues could reach nearly $4.5 billion by 2011.
Exhibit at DEA museum traces history of drug diversion
DEA kicks off exhibit about drug diversion and abuse.
Hospitals must disclose secondary diagnoses
New Web page details POA reporting requirements
Rite Aid addresses union protest
Rite Aid responds to union protest
PDPs owe Medicare $4.4 billion for 2006
Medicare Part D prescription drug plans owe more than $4 billion to CMS
CommunityCare Rx provides more than 70,000 MTM services
More than 70,000 medication therapy management services have been offered through the Community Care Rx (CCRx) program, according to an announcement from Mirixa
Database offers NPI and prescriber data
PDX-NHIN and Health Market Science will jointly market the HMS database with 1.8 million prescriber records including NPI numbers
Michigan pharmacists launch MTM company
Michigan Pharmacists Association announces plans for a medication therapy management company to expand MTM opportunities
Giant Eagle expands $4 generic prescription program
Giant Eagle expands $4 generic prescription drug program
OIG thinks generics should be subject to more Medicaid rebates
A new report by the Office of Inspector General found that some generic manufacturers keep raising their drug prices above the inflationary rate, making them deserve to pay more Medicaid rebates
Public health group opposes feminine hygiene douching practices
APHA adopts policy against feminine hygiene douching practices
AstraZeneca's Purple Plus members offered savings on Nexium
AstraZeneca launches Nexium savings program for Purple Plus members
NACDS, NCPA slap CMS with suit over AMP
NACDS and NCPA sue to block implementation of the average manufacturer price rule set to take effect in January.
Health professionals think Part D has hurt long-term care patients
A new survey of four health disciplines reveals that they think Medicare Part D has hurt the care provided in long-term care facilities.
Survey says: Seniors satisfied with Medicare Rx benefit
Seniors are satisfied with Medicare Part D drug benefit.
Many drugs in works to inhibit drug-resistant strains of MRSA
Reinforcements on way to fight infectious diseases.
Rite Aid is target of protest by unions
Union protest targets Rite Aid.
BIO issues white paper on comparative effectiveness
In a new paper, the Biotechnology Industry Organization reveals it has reservations about the use of comparative effectiveness in reviewing products.
Humana exempts members from co-pay for preferred generics
Humana announced that, starting in January, members in its Medicare drug plans don't have to pay a co-pay for Tier 1 generics.
CVS pharmacists help patients manage diabetes
CVS pharmacists help diabetes patients.
Marketing of aprotinin halted until FDA can evaluate safety
Bayer suspends worldwide marketing of antifibrolytic Trasylol.
FDA asks for recall of dietary supplements for men
FDA requests recall of True Man Sexual Energy, Energy Max dietary supplements.
Dietary supplement adverse event reporting rules effective Dec. 22
Adverse event reporting rules for dietary supplements effective Dec. 22.
